Hudson Executive Capital LP Q3 2023 significant ownership

Hudson Executive Capital LP is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Hudson Executive Capital LP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ViewRay, Inc.July 21, 20236,752,0933.7%
Akoya Biosciences, Inc.February 07, 20231,892,2045.0%
Liberated Syndication Inc.March 23, 20222,400,0008.6%
eHealth, Inc.March 11, 2022750,5012.8%
Talkspace, Inc.November 17, 202117,980,60011.2%
USA TECHNOLOGIES INCFebruary 26, 202111,995,76516.9%
Cardtronics plcDecember 15, 20208,644,88019.4%
TIVITY HEALTH, INC.May 11, 20204,795,3109.9%
EAGLE PHARMACEUTICALS, INC.January 16, 2020361,8972.6%
Corindus Vascular Robotics, Inc.Sold outOctober 31, 201900.0%
AtriCure, Inc.October 09, 20181,882,494-
CABOT MICROELECTRONICS CORPApril 04, 20171,234,3004.9%
HeartWare International, Inc.Sold outJune 28, 20160-

Compare quarters

Export Hudson Executive Capital LP's holdings